1. Meeting and attendance
(1) The convening of the meeting
1. Meeting time: April 15, 2021
2. Meeting place: company meeting room
3. Meeting method: on-site
4. Convener of the meeting: Board of Directors
5. Moderator of the meeting: Chairman Wang Xueliang
6. Explanation of legality, compliance, and constitutionality of the convening situation:
The procedures for convening, convening, and reviewing proposals are in compliance with the "Company Law" and "Articles of Association" and the relevant provisions of the company's management system on the convening of general meetings of shareholders, and the resolutions made are legal and valid.

(2) Meeting attendance
A total of 11 shareholders attended and authorized to attend this general meeting, with a total of 109,172,000 voting shares, accounting for 86.64% of the company's total voting shares.

(3) The company's directors, supervisors, and senior management personnel attending or attending the general meeting of shareholders as non-voting delegates
1. There are 6 incumbent directors of the company and 3 were present. Directors Chen Daofeng, Sun Pengjun and Wang Zheng were absent due to personal reasons (if applicable);
2. 3 of the company's current supervisors, 2 of them were present, and Xia Xiang, the supervisor, was absent due to personal reasons (if applicable);
3. The secretary of the company's board of directors attended the meeting;
Senior executives of the company Wang Xueliang, Yuan Zhao, Zhao Junling, Tao Xu, Cai Liying and Qu Shen attended the meeting

2. Review of the proposal
(1) Deliberated and approved the "Proposal on Amending the Articles of Association"
1. The content of the proposal:
The report has been disclosed in the "Announcement on the Proposed Amendment of the Articles of Association" (Announcement No.: 2021-004) published on the Information Disclosure Platform of the National SME Share Transfer System (www.neeq.com.cn).
2. The result of the voting on the proposal:
109,172,000 shares were approved, accounting for 100% of the total number of shares with voting rights in this general meeting; 0 shares opposed, accounting for 0% of the total number of shares with voting rights in this general meeting; 0 shares abstained, accounting for this general meeting of shareholders 0% of the total number of voting shares.
3. Avoid voting
The proposal does not involve related-party transactions, and there is no need to avoid voting.

(2) Deliberated and approved the "Proposal on Formulating the "Work Rules for Independent Directors""
1. The content of the proposal:
According to the company's articles of association and actual operating conditions, the company formulated the "Independent Directors' Working Rules."
2. The result of the voting on the proposal:
109,172,000 shares were approved, accounting for 100% of the total number of shares with voting rights in this general meeting; 0 shares opposed, accounting for 0% of the total number of shares with voting rights in this general meeting; 0 shares abstained, accounting for this general meeting of shareholders 0% of the total number of voting shares.
3. Avoid voting
The proposal does not involve related transactions, and there is no need to avoid voting.

(3) Examined and approved the "Proposal on Appointment of Company Directors"
1. The content of the proposal:
The report has been disclosed in the "Announcement of Appointment of Directors" (Announcement No.: 2021-007) published on the Information Disclosure Platform of the National SME Share Transfer System (www.neeq.com.cn).
2. The result of the voting on the proposal:
109,172,000 shares were approved, accounting for 100% of the total number of shares with voting rights in this general meeting; 0 shares opposed, accounting for 0% of the total number of shares with voting rights in this general meeting; 0 shares abstained, accounting for this general meeting of shareholders 0% of the total number of voting shares.
3. Avoid voting
The proposal does not involve related-party transactions, and there is no need to avoid voting.

3. The effective status of the proposals for changes in directors, supervisors and senior management personnel reviewed by this general meeting of shareholders (if any)

4. List of available documents
1. Resolutions of the first extraordinary general meeting of shareholders of Shanghai Yanan Pharmaceutical Yangpu Co., Ltd. in 2021
2. Minutes of the first extraordinary general meeting of shareholders of Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd. in 2021

Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd.
Board of Directors
April 16, 2021